For the year ending 2025-12-31, LUNG made $90,497K in revenue. -$53,756K in net income. Net profit margin of -59.40%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 90,497 | 83,789 | ||
| Cost of goods sold | 23,358 | 21,788 | ||
| Gross profit | 67,139 | 62,001 | ||
| Research and development | 19,491 | 17,570 | ||
| Selling, general and administrative | 101,311 | 102,135 | ||
| Total operating expenses | 120,802 | 119,705 | ||
| Loss from operations | -53,663 | -57,704 | ||
| Interest income | 2,651 | 5,061 | ||
| Interest expense | 3,155 | 3,507 | ||
| Other income, net | 790 | 256 | ||
| Net loss before tax | -53,377 | -55,894 | ||
| Income tax expense | 626 | 500 | ||
| Net loss | -54,003 | -56,394 | ||
| Currency translation adjustment | 269 | -466 | ||
| Change in unrealized losses on marketable securities | -22 | -61 | ||
| Total other comprehensive income (loss) | 247 | -527 | ||
| Comprehensive loss | -53,756 | -56,921 | ||
| Basic EPS | -1.33 | -1.44 | ||
| Diluted EPS | -1.33 | -1.44 | ||
| Basic Average Shares | 40,685,934 | 39,111,073 | ||
| Diluted Average Shares | 40,685,934 | 39,111,073 | ||
Pulmonx Corp (LUNG)
Pulmonx Corp (LUNG)